CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer

Cancer Research

Volumn 75, Issue 20, 2015, Pages 4312-4321

  Zhang, Qianfei ^a   Qin, Jilong ^b   Zhong, Lin ^c   Gong, Lei ^c   Zhang, Bing ^d   Zhang, Yan ^a   Gao, Wei Qiang ^a,e  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c YANTAI YUHUANGDING HOSPITAL   (China)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e Collarative Innovation Center of Systems Biomedicine ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; INTERLEUKIN 4; RANTES; DNA BINDING PROTEIN; GFI1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUMINAL BREAST CANCER; LUNG METASTASIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH2 CELL; TRIPLE NEGATIVE BREAST CANCER; TUMOR PROMOTION; ANIMAL; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; CELL DIFFERENTIATION; CELL TRANSFORMATION; CYTOLOGY; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; FEMALE; GENE DELETION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG TUMOR; METABOLISM; METASTASIS; MULTICELLULAR SPHEROID; PATHOLOGY; SECONDARY; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL CULTURE;

ANIMALS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CCL5; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENE DELETION; GENE EXPRESSION; HUMANS; INTERLEUKIN-4; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; MYELOID CELLS; NEOPLASM METASTASIS; RECEPTORS, CCR3; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; T-LYMPHOCYTE SUBSETS; TH2 CELLS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84940925840     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3590     Document Type: Article

References (26)

1. Polyak K, Metzger Filho O. SnapShot: breast cancer. Cancer Cell 2012;22:562-562.e1.
2. Ignatiadis M, Sotiriou C. Luminal breast cancer: from biology to treatment. Nat Rev Clin Oncol 2013;10:494-506.
3. Pakianathan DR, Kuta EG, Artis DR, Skelton NJ, Hebert CA. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5. Biochemistry 1997;36:9642-8.
4. Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, et al. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 1999;59:4681-7.
5. Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, et al. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res 2006;12:4474-80.
6. Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 2001;7:285-9.
7. Zhang Y, Lv D, Kim HJ, Kurt RA, Bu W, Li Y, Ma X. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells. Cell Res 2013;23:394-408.
8. Smalley MJ. Isolation, culture and analysis of mouse mammary epithelial cells. Methods Mol Biol 2010;633:139-70.
9. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009;16: 91-102.
10. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acinigrowninthree-dimensional basement membrane cultures. Methods 2003;30:256-68.
11. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 2008;13:141-52.
12. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expressionof polyomavirus middleToncogene:atransgenic mousemodel for metastatic disease. Mol Cell Biol 1992;12:954-61.
13. Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, et al. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001;61:8298-305.
14. Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M, et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 2002;62:1093-102.
15. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-6.
16. Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, et al. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 2003;198:1741-52.
17. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
18. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. Progression of interleukin-2 (IL-2)-dependent rat T-cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 1993;13:1759-68.
19. Hock H, Hamblen MJ, Rooke HM, Traver D, Bronson RT, Cameron S, et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 2003;18:109-20.
20. Karsunky H, Zeng H, Schmidt T, Zevnik B, Kluge R, Schmid KW, et al. Inflammatory reactions and severe neutropenia in mice lacking the tran-scriptional repressor Gfi1. Nat Genet 2002;30:295-300.
21. Zhu J, Guo L, Min B, Watson CJ, Hu-Li J, Young HA, et al. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 2002;16:733-44.
22. Shinnakasu R, Yamashita M, Kuwahara M, Hosokawa H, Hasegawa A, Motohashi S, et al. Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation. J Biol Chem 2008;283: 28216-25.
23. Appay V, Rowland-Jones SL. RANTES: a versatile and controversial che-mokine. Trends Immunol 2001;22:83-7.
24. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277: 2005-7.
25. Luther SA, Cyster JG. Chemokines as regulators of T-cell differentiation. Nat Immunol 2001;2:102-7.
26. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-63.